Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Short-term Investments (2018 - 2025)

Dna X (SONM) has disclosed Short-term Investments for 6 consecutive years, with $3.4 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Short-term Investments changed N/A year-over-year to $3.4 million, compared with a TTM value of $3.4 million through Jun 2025, changed N/A, and an annual FY2024 reading of $2.7 million, up 1269.04% over the prior year.
  • Short-term Investments was $3.4 million for Q2 2025 at Dna X, up from $2.8 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $3.4 million in Q2 2025 and bottomed at $197000.0 in Q4 2023.
  • Average Short-term Investments over 4 years is $2.0 million, with a median of $2.7 million recorded in 2024.
  • The sharpest move saw Short-term Investments decreased 8.12% in 2021, then skyrocketed 1269.04% in 2024.
  • Year by year, Short-term Investments stood at $1.0 million in 2021, then crashed by 81.08% to $197000.0 in 2023, then surged by 1269.04% to $2.7 million in 2024, then rose by 27.4% to $3.4 million in 2025.
  • Business Quant data shows Short-term Investments for SONM at $3.4 million in Q2 2025, $2.8 million in Q1 2025, and $2.7 million in Q4 2024.